Abstract:Introduction: Brain is a major site of metastasis for lung cancer, and effective therapy for developed brain metastasis (BM) is limited. Prophylactic cranial irradiation (PCI) has been shown to reduce BM rate and improve survival in small cell lung cancer, but this result was not replicated in unselected non-small cell lung cancer (NSCLC) and had the risk of inducing neurocognitive dysfunctions. We aimed to develop a radiomics BM prediction model for BM risk stratification in NSCLC patients. Methods: 256 NSCLC patients with no BM at baseline brain magnetic resonance imaging (MRI) were selected; 128 patients developed BM within three years after diagnosis and 128 remained BM-free. For radiomics analysis, both the BM and non-BM groups were randomly distributed into training and testing datasets at an 70%:30% ratio. Both brain MRI (representing the soil) and chest computed tomography (CT, representing the seed) radiomic features were extracted to develop the BM prediction models. We first developed the radiomic models using the training dataset (89 non-BM and 90 BM cases) and subsequently validated the models in the testing dataset (39 non-BM and 38 BM cases). A radiomics BM score (RadBM score) was generated, and BM-free survival were compared between RadBM score-high and RadBM score-low groups. Results: The radiomics model developed from baseline brain MRI features alone can predict BM development in NSCLC patients. A fusion model integrating brain MRI features with primary tumor CT features (seed-and-soil model) provided synergetic effect and was more efficient in predicting BM (areas under the receiver operating characteristic curve 0.84 (95% confidence interval: 0.80−0.89) and 0.80 (95% confidence interval: 0.71−0.88) in the training and testing datasets, respectively). BM-free survival was significantly shorter in the RadBM score-high group versus the RadBM score-low group (Log-rank, p < 0.001). Hazard ratios for BM were 1.056 (95% confidence interval: 1.044−1.068) per 0.01 increment in RadBM score. Cumulative BM rates at three years were 75.8% and 24.2% for the RadBM score-high and RadBM score-low groups, respectively. Only 1.2% (7/565) of the BM lesions were located within the hippocampal avoidance region. Conclusion: The results demonstrated that intrinsic features of a non-metastatic brain exert a significant impact on BM development, which is first-in-class in metastasis prediction studies. A radiomics BM prediction model utilizing both primary tumor and pre-metastatic brain features might provide a useful tool for individualized PCI administration in NSCLC patients more prone to develop BM.

A Clinical Prediction Model for the Presence of Brain Metastases from Colorectal Cancer

Factors Prognostic for Brain Metastases from Colorectal Cancer: A Single-Center Experience in China.

Predictive and Prognostic Assessment Models for Tumor Deposit in Colorectal Cancer Patients with No Distant Metastasis

Prognosis of lung cancer with simple brain metastasis patients and establishment of survival prediction models: a study based on real events

Risk Factors on the Incidence and Prognostic Effects of Colorectal Cancer With Brain Metastasis: A SEER-Based Study

Establishment of a prognostic risk prediction modelfor non-small cell lung cancer patients with brainmetastases: a retrospective study

Development and External Validation of a Prediction Model for Brain Metastases in Patients with Metastatic Breast Cancer

Survival Analysis, Clinical Characteristics, and Predictors of Cerebral Metastases in Patients with Colorectal Cancer

Prognostic Factors and Multidisciplinary Treatment Modalities for Brain Metastases from Colorectal Cancer: Analysis of 93 Patients.

NCCBM, a Nomogram Prognostic Model in Breast Cancer Patients With Brain Metastasis

Individualized Prediction of Colorectal Cancer Metastasis Using a Radiogenomics Approach

Risk factors and prognostic factors for pulmonary large cell neuroendocrine carcinoma with brain metastasis

A nomogram prediction model based on clinicopathological combined radiological features for metachronous liver metastasis of colorectal cancer

A meta-analysis of models for predicting the incidence of brain metastasis in patients with lung cancer.

Incidence and predictors of brain metastasis in colorectal cancer patients

A “Seed-and-soil” Radiomics Model Predicts Brain Metastasis Development in Lung Cancer: Implications for Risk-Stratified Prophylactic Cranial Irradiation

Nomograms for predicting overall survival in colorectal cancer patients with metastasis to the liver, lung, bone, and brain

Nomogram to Predict the Risk and Survival of Synchronous Bone Metastasis in Colorectal Cancer: a Population-Based Real-World Analysis.

A Comprehensive Prognostic Model for Colorectal Cancer Liver Metastasis Recurrence After Neoadjuvant Chemotherapy

Development and Validation of Risk and Prognostic Nomograms for Bone Metastases in Chinese Advanced Colorectal Cancer Patients

Construction of brain metastasis prediction model in limited stage small cell lung cancer patients without prophylactic cranial irradiation